Development of evidence -based Rorschach differential diagnostics
Project/Area Number |
18K03133
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 10030:Clinical psychology-related
|
Research Institution | Gifu University |
Principal Investigator |
|
Project Period (FY) |
2018-04-01 – 2023-03-31
|
Project Status |
Completed (Fiscal Year 2022)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
Keywords | ロールシャッハ法 / 鑑別指標 / 統合失調症 / 自閉アスペルガー症 / パーソナリティ障害 / BPD / 鑑別診断 / ロールシャッハ / ロジスティック回帰分析 / R-PAS |
Outline of Final Research Achievements |
The results of the Rorschach in several clinical groups (schizophrenia and personality disorder/autistic Asperger's) showed that 1) Xu% has the power to differentiate schizophrenia from other clinical groups, 2) the number of popular responses (P) on card 6 is significantly higher in the personality disorder group than in other clinical groups, In other words, it has value as a differential index and 3) whether or not "black" (C') was used for that response can differentiate schizophrenia from autistic Asperger's.
|
Academic Significance and Societal Importance of the Research Achievements |
統合失調症,自閉スペクトラム症,パーソナリティ障害とを鑑別し得る指標を抽出し得たことで,当初予定していた方法論とは異なりはしたものの,ある程度所期の目的は達成できたと思われる。今回得られた指標は,臨床実践の場において鑑別に困難を極めるケースにおいて,その判断の参考になり得よう。 適切な診断をなすことで,患者に不利益を回避させ,より精度の高い治療を提供できることは,社会的に見ても極めて意義のあることだと思われる。
|
Report
(6 results)
Research Products
(9 results)